Definitive Contract 75N92020C00020
Award Date
8/28/20
Potential Completion Date
8/27/23
Potential Value
$5.3M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Maxim Biomedical, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $49,536,000.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned business located in Rockville, Maryland. The contract is for the delivery of over-the-counter (OTC) COVID-19 tests with a period of performance through March 19, 2025. Maxim Biomedical has previously received other...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a self-certified small disadvantaged, woman-owned, and Asian-Pacific American-owned business, for the development of lateral flow immunoassays (LFIs). The $251,080.00 contract, which has a Coronavirus COVID-19 national interest action code, is for the delivery of LFIs to support COVID-19 testing efforts across the Department of...
Minute Molecular Diagnostics, Inc. was awarded a definitive, firm fixed price contract valued at seventeen million, five hundred ninety thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for the RADX TECH PROJECT 2200 to develop a high-throughput, fast-turnaround, field-deployable COVID-19 molecular diagnostic system. Work will be performed in Evanston, Illinois with a period of performance...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $22.57 million firm fixed price definitive contract to Flambeau Diagnostics LLC of Monona, Wisconsin. The contract is for the delivery of RADX TECH 2375 point-of-need, saliva-based COVID-19 testing platforms over a twenty-month period ending in March 2023. No subcontractors or set aside designations were indicated. The award supports the NIH's ongoing efforts to...
Materials & Machines Corp of America (Matmacorp) has been awarded a $5.3 million firm fixed price definitive contract by the National Institutes of Health's National Heart Lung and Blood Institute to support the Rapid Acceleration of Diagnostics Technology program. Under project number 5218, Matmacorp will establish SARS-CoV-2 high throughput laboratory capacity to scale up COVID-19 testing as part of the RADx initiative to accelerate the development, validation, and implementation of...
This is a $5,240,000.00 firm fixed price definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lumiradx, Inc., a foreign-owned, for-profit organization. The contract is for Lumiradx to provide a SARS-CoV-2 & Flu A/B high sensitivity antigen assay under the RADX Tech program. The contract has an ultimate completion date of May 31, 2022 and was awarded on September 30, 2021. This contract is not associated with any set-aside designation.
This contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Luminostics Inc., a for-profit medical technology company. The $39,067,500.00 Firm Fixed Price contract is for the RADX-TECH program to develop and deliver a smartphone-based point-of-care test for rapid SARS-CoV-2 antigen detection from nasal swabs. This contract was not set aside for any particular business type. Luminostics has received prior federal contract and grant awards related to...
This is a $1,633,610.00 time and materials purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biocomx, a minority-owned nonprofit organization. The contract is part of the NIH's National Institute of Biomedical Imaging and Bioengineering (NIBIB) COVID-19 RADx initiative, which aims to accelerate the development and implementation of rapid innovative diagnostics for COVID-19. Under this contract,...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics through...